DrugPatentWatch Database Preview
Investigational Drug Information for Imeglimin
Email this page to a colleague
What is the drug development status for Imeglimin?
Imeglimin is an investigational drug.
There have been 6 clinical trials for Imeglimin.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2013.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Liver Diseases. The leading clinical trial sponsors are Poxel SA and [disabled in preview].
There are thirty-one US patents protecting this investigational drug and three hundred and forty-five international patents.
Summary for Imeglimin
| US Patents | 31 |
| International Patents | 345 |
| US Patent Applications | 70 |
| WIPO Patent Applications | 44 |
| Japanese Patent Applications | 7 |
| Clinical Trial Progress | Phase 2 (2013-01-01) |
| Vendors | 22 |
Recent Clinical Trials for Imeglimin
| Title | Sponsor | Phase |
|---|---|---|
| Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects | Poxel SA | Phase 1 |
| Bioequivalence of Imeglimin Tablet Formulations | Poxel SA | Phase 1 |
| Effect of Cimetidine on the PK of Imeglimin | Poxel SA | Phase 1 |
Clinical Trial Summary for Imeglimin
Top disease conditions for Imeglimin
Top clinical trial sponsors for Imeglimin
US Patents for Imeglimin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Imeglimin | ⤷ Try it Free | Biguanide compositions and methods of treating metabolic disorders | ELCELYX THERAPEUTICS, INC. (San Diego, CA) | ⤷ Try it Free |
| Imeglimin | ⤷ Try it Free | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try it Free |
| Imeglimin | ⤷ Try it Free | Biguanide compositions and methods of treating metabolic disorders | ELCELYX THERAPEUTICS, INC. (San Diego, CA) | ⤷ Try it Free |
| Imeglimin | ⤷ Try it Free | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk | ELCELYX THERAPEUTICS, INC. (San Diego, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Imeglimin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Imeglimin | Argentina | AR091089 | 2031-01-07 | ⤷ Try it Free |
| Imeglimin | Argentina | AR091739 | 2031-01-07 | ⤷ Try it Free |
| Imeglimin | Australia | AU2011317140 | 2030-10-19 | ⤷ Try it Free |
| Imeglimin | Australia | AU2011317143 | 2030-10-19 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
